Actively Recruiting
Evaluating Hyperbaric Oxygen Therapy for Peripheral Neuropathy Caused by Nab-Paclitaxel in Breast Cancer Patients A Randomized Clinical Trial
Led by Guangdong Provincial People's Hospital · Updated on 2026-09-30
160
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether hyperbaric oxygen therapy can reduce symptoms of peripheral neuropathy caused by the chemotherapy drug nab-paclitaxel in women with breast cancer. The study aims to improve patient-reported quality of life by comparing this therapy to standard care in a randomized clinical trial setting. This research is conducted by Guangdong Provincial Peoples Hospital and focuses on treatment effects in early-stage or locally advanced breast cancer patients who have completed specific chemotherapy. Participants are assigned to one of two groups one receives hyperbaric oxygen therapy daily for 90 to 120 minutes per session, totaling 20 to 30 treatments at 100% oxygen and 2.0 ATA pressure the other group receives standard care without this therapy. The study monitors effects over time, including a 6-week intervention period and follow-ups extending up to 12 months after treatment ends. During the study, participants undergo regular assessments including patient questionnaires on neuropathy symptoms and quality of life, neuropathic pain evaluations, nerve conduction studies, and clinical toxicity grading. These assessments occur at baseline, after the 6-week intervention, and at 1, 3, 6, and 12 months post-intervention. The main outcome measured is the change in chemotherapy-induced peripheral neuropathy symptoms, with safety and nerve function also monitored throughout the study duration.
CONDITIONS
Brief Title
Efficacy and Safety of Hyperbaric Oxygen Therapy in Improving Nab-paclitaxel-Induced Peripheral Neuropathy
Research Team
K
Kun Wang, PhD
Y
Yingcong Lin, Master of Medicine
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here